← all drugs
Irinotecan Hydrochloride Injection
being discontinued · Oncology · Snapshot: 2026-08-25
- Manufacturers listed
- Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.), Ingenus Pharmaceuticals LLC
- Machine-readable
- JSON for this drug
Presentations (4)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Irinotecan Hydrochloride, Injection, 100 mg/5 mL (NDC 25021-230-05) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | unknown | 09/26/2025 |
| Irinotecan Hydrochloride, Injection, 40 mg/2 mL (NDC 50742-401-02) | Ingenus Pharmaceuticals LLC | unknown | 02/24/2026 |
| Irinotecan Hydrochloride, Injection, 40 mg/2 mL (NDC 25021-230-02) | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | unknown | 09/26/2025 |
| Irinotecan Hydrochloride, Injection, 100 mg/5 mL (NDC 50742-402-05) | Ingenus Pharmaceuticals LLC | unknown | 02/24/2026 |
History
Daily change tracking began 2026-08-25 (index founding). Status flips and availability changes will accumulate here.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.